Takeda Presents New Exploratory Analysis Showing Patients Treated With LIVTENCITY (Maribavir) Had Re

发布时间：2022-04-27

分享到：

QQ空间新浪微博腾讯微博微信更多

Data Include Exploratory Analysis Showing LIVTENCITY Treated Patients With Post-Transplant Cytomegalovirus (CMV) Infections/Disease Had Reductions in Hospitalizations (34.8%; p=0.021) and Length of Hospital Stay (53.8%; p=0.029) Compared to Those Treated With Conventional Antiviral Therapies1*
Post-Hoc Analyses by Subgroup Showed Shorter Time to First Confirmed CMV DNA Level Less Than the Lower Limit of Quantification ( Data Presented at the 2022 Tandem Meetings and European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) Builds Upon the Growing Body of Evidence Supporting LIVTENCITY’s Role in Redefining Treatment for Patients With Post-Transplant CMV Infections1

来源：

作者：

上一篇：钟化发布用于识别COVID-19奥密克戎(BA.1)和“隐匿性”奥密克戎(BA.2)变异株的新款PCR检测试剂盒

下一篇：CellPoint Digital Partners With MTC Game to Enable More Payment Options for Gamers

>相关文章

Skyline Development：超级豪宅The One Bel-Air Mega Mansion开发商寻求新投资者，截止日期为3月18日2022-03-17
Wipro任命Anis Chenchah2022-04-14
Mavenir宣布在其4G/5G融合云原生OpenRAN和分组核心上提供全面的2G和3G支持2020-11-12
Dave Powell的“世纪年份葡萄酒”将以非同质化代币形式出售2021-10-21
MEDIUM to Establish Busan International Blockchain Business Center with NHN, Brave Entertainment, an2022-04-01
I Squared Capital为宣布基础设施信贷策略8亿美元战略合作2020-09-11
Public Wants Greater Focus on Science-Based Decision-Making Says New International Survey from Phili2020-09-16
可持续农业数字平台nurture.farm扩展成为OpenAg网络的一部分2021-07-20

免责声明：中国新金融网所载文章、数据等内容仅代表作者个人观点，与中国新金融网无关，其陈述、观点仅供参考。请读者自行考量，且风险自担。版权声明：中国新金融网所载文章部分来源网络，如若不允许转载，请联系我们，我们将及时撤除。